|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UR 545 Institut National de la Santé et de la Recherche Médicale, Département d'Athérosclérose, Institut Pasteur de Lille and the Faculté de Pharmacie, Université de Lille II, Lille, France (O.B., H.D., J.C.F., B.S.); Canada Research Chair in Pharmacogenomics, Oncology and Molecular Endocrinology Research Center, CHUL Research Center and Faculty of Pharmacy, Laval University, Quebec, Canada (H.G., L.V. C.G.); and Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (Y.I., A.K., F.G.)
UDP-glucuronosyltransferase (UGT) enzymes catalyze the glucuronidation reaction, which is a major pathway in the catabolism and elimination of numerous endo- and xenobiotics. Among the UGT enzyme family members, the UGT1A7, UGT1A8, UGT1A9, and UGT1A10 isoforms are issued from a single gene through differential splicing. However, these enzymes display distinct tissue-specific expression patterns. Indeed, UGT1A7, UGT1A8, and UGT1A10 are exclusively expressed in extrahepatic tissues, whereas UGT1A9 transcripts are found at high concentrations in liver. In the present study, we report that the liver-enriched hepatocyte nuclear factor 4 (HNF4)-
controls the hepatic expression of the UGT1A9 enzyme. Liver-specific disruption of the HNF4
gene in mice drastically decreases liver UGT1A9 mRNA levels. Furthermore, an HNF4
response element (HNF4
RE) was identified in the promoter of human UGT1A9 at position -372 to -360 base pairs by transient transfection, electrophoretic mobility shift assays, and chromatin immunoprecipitation experiments. It is interesting that this response element is absent in the proximal UGT1A7, UGT1A8, and UGT1A10 gene promoters. In conclusion, the present study identifies HNF4
as a major factor for the control of UGT1A9 hepatic expression and suggests that the absence of UGT1A7, UGT1A8, and UGT1A10 expression in the liver is caused by, at least in part, a few base pair changes in their promoter sequences in the region corresponding to the HNF4
RE of the UGT1A9 gene.
Address correspondence to: Dr. Bart Staels, Unité INSERM 545, Institut Pasteur de Lille, 1, rue du Pr Calmette, BP 245, 59019 Lille, France. E-mail: bart.staels{at}pasteur-lille.fr
This article has been cited by other articles:
![]() |
P. Ungaro, R. Teperino, P. Mirra, A. Cassese, F. Fiory, G. Perruolo, C. Miele, M. Laakso, P. Formisano, and F. Beguinot Molecular Cloning and Characterization of the Human PED/PEA-15 Gene Promoter Reveal Antagonistic Regulation by Hepatocyte Nuclear Factor 4{alpha} and Chicken Ovalbumin Upstream Promoter Transcription Factor II J. Biol. Chem., November 7, 2008; 283(45): 30970 - 30979. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inoue and M. Negishi Nuclear Receptor CAR Requires Early Growth Response 1 to Activate the Human Cytochrome P450 2B6 Gene J. Biol. Chem., April 18, 2008; 283(16): 10425 - 10432. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ramirez, W. Liu, S. Mirkov, A. A. Desai, P. Chen, S. Das, F. Innocenti, and M. J. Ratain Lack of Association between Common Polymorphisms in UGT1A9 and Gene Expression and Activity Drug Metab. Dispos., December 1, 2007; 35(12): 2149 - 2153. [Abstract] [Full Text] [PDF] |
||||